Sunday, September 13, 2020

AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases (Leah Rosenbaum/Forbes)

Leah Rosenbaum / Forbes:
AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases  —  Startups that want to leverage artificial intelligence in drug discovery are a dime a dozen in today's biotech landscape.



at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Disney, Fox, and WBD say they have agreed to discontinue their Venu Sports streaming joint venture and will focus on existing products and distribution channels (Alex Weprin/The Hollywood Reporter)

Alex Weprin / The Hollywood Reporter : Disney, Fox, and WBD say they have agreed to discontinue their Venu Sports streaming joint venture...